 "We currently are using the most advanced commercial infrared sensors in our BioScanIR system, which were also developed with MDA funding. These sensors have repeatedly demonstrated their value to researchers, surgeons and clinicians at world renowned medical centers. Our goal is to continue to aggressively advance QWIP technology forward and this project is a perfect opportunity to do so. |
OmniCorder will serve as the primary contractor on the project and will develop a multi-band high resolution QWIP infrared detector to be used for both missile defense and medical imaging applications.
This sensor is of great interest to the Department of Defense for missile defense applications and equally important to OmniCorder for future medical imaging applications. OmniCorder will be collaborating with a team comprised of the leading R&D institutions in this field including the Jet Propulsion Laboratory, the Army Research Laboratory and the Goddard Space Flight Center.
"We are honored to be working with the leading experts in this field", said Mark A. Fauci, OmniCorder's Founder, President, and CEO. "This is a very important part of the company's research and development efforts.
"We currently are using the most advanced commercial infrared sensors in our BioScanIR system, which were also developed with MDA funding. These sensors have repeatedly demonstrated their value to researchers, surgeons and clinicians at world renowned medical centers. Our goal is to continue to aggressively advance QWIP technology forward and this project is a perfect opportunity to do so."
There are many potential advantages in employing a high resolution, multi-band infrared detector for medical imaging applications. This sensor will be capable of analyzing and displaying multiple bands of infrared energy simultaneously and it will have many times higher resolution as compared to current sensors. It will permit complex analysis of diagnostically important characteristics of living tissue, in real time.
The new infrared sensor is expected to make many new medical imaging applications possible for the first time and have a substantial impact in the fields of functional and molecular imaging. This technology can potentially further improve researchers' and clinicians' ability to develop new drugs faster and less expensively, help clinicians to use drugs more effectively on patients, as well as assist surgeons in planning, guiding and assessing surgical procedures. Other potential applications include earlier diagnosis of diseases such as breast and cervical cancers.
Related Links
Lockheed Martin Wins $812M Deal For Sea-Based Missile Defense
Moorestown - Oct 13, 2003